ArticleRMD open2026

Long-term osteoprotective effects of IL-17A blockade with secukinumab in psoriatic arthritis: data from the PSARTROS-II study.

Louis Schuster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.